Connect with us
Rovi obtained a gross operating result of €279 million in 2022. Sales of the heparin division increased by 9% in 2022 compared to 2021, up to...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...
The Spanish pharmaceutical company Rovi achieved a net profit of $60.3 million (€51 million) from January to June, compared to $35 million (€29.6 million) a year...
Norbel Inversions, the investment vehicle of the López-Belmonte family, owners of the pharmaceutical company, wants to sell 1.6 million shares. The transaction will be carried out...
In February 2021, Rovi announced that it expected operating income for the current fiscal year to increase by 20% to 30%, including the production of Moderna's...